Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 3/25/2026Innovent Reports Positive Phase 3 STAR Results for IBI302 in nAMD
  • 3/25/2026Hope Medicine Advances HMI-115 Into Phase III for Endometriosis
  • 3/24/2026LG Chem's Tigulixostat Advances to Phase 3 in China Through Innovent P...
  • 3/24/2026Sanofi Opens Chengdu Innovation Hub to Strengthen China Operations
  • 3/24/2026RemeGen's Disitamab Vedotin Approved in China for HER2-Low Breast Canc...
  • 3/23/2026Dizal Reports Positive Phase III WU-KONG28 Results for Sunvozertinib i...
  • 3/23/2026CTTQ Reports Updated Phase I Data for EGFR/c-MET Bispecific TQB2922 in...
  • 3/23/2026Hengrui Expands HER3 ADC SHR-A2009 Data Across Mono and Combination Se...
  • 3/23/2026MediLink Thera Reports Phase II Activity for YL202/BNT326 in NSCLC
  • 3/23/2026HUTCHMED Advances HMPL-760 Into Phase III Trial for DLBCL in China
  • 3/20/2026Cloudbreak Pharma Withdraws China IND for CBT-009, Refocuses Ophthalmo...
  • 3/20/2026Kintor Reports Positive Phase III Results for First-in-Class Hair Loss...
  • 3/20/2026NovaBridge Secures FDA Alignment on Accelerated Pathway for Givastomig...
  • 3/20/2026ELCC 2026: BioKin–Henlius Combo Shows First-Line Promise in ES-SCLC
  • 3/17/2026Gyre Thera Liver Fibrosis Drug Receives Priority Review in China
  • 3/17/2026Essight Wins FDA Clearance for First Clinical Trial of RAS G12V Bispec...
  • 3/17/2026Fosun Pharma Subsidiary Secures China Approval for Novel Hair-Loss The...
  • 3/16/2026KangaBio Advances Oncology Pipeline with FDA IND Clearance
  • 3/16/20263SBio Wins U.S. FDA Clearance to Advance Metabolic Disease Antibody SS...
  • 3/16/2026CirCode Wins FDA Clearance to Test Circular RNA Therapy
  • 3/13/2026CMS Wins NMPA Approval for Desidustat Tablets to Treat Renal Anemia
  • 3/13/2026UniXell Secures FDA Clearance to Begin Clinical Testing of iPSC-Derive...
  • 3/12/2026Hansoh Launches Phase 3 Trial of B7-H3 ADC HS-20093 With PD-L1 Therapy...
  • 3/10/2026Novo Nordisk and United Labs Report ~20% Weight Loss With Next‑Gen Tr...
  • 3/10/2026Ascletis Reports Positive Phase 2 Results for Monthly ASC30 Obesity Th...
  • 3/10/2026CSPC Subsidiary Registers Phase I/II Trial for In Vivo CD19 CAR-T Ther...
  • 3/10/2026Laekna and Eli Lilly Complete Phase 1 Study of ActRIIA Antibody LAE102...
  • 3/10/2026Junshi Secures NMPA Acceptance for Subcutaneous Toripalimab Across 12 ...
  • 3/9/2026Biocytogen Achieves Key Clinical Milestone as IDEAYA Initiates Phase I...
  • 3/9/2026Regeneron Highlights Positive Chinese Phase III Data for Obesity Candi...
  • Page:3/22 Total number of articles:649: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group